Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SEELOS THERAPEUTICS, INC. | Chief Financial Officer | Common Stock | 86.9K | $95.3K | $1.10 | Feb 29, 2024 | Direct |
SEELOS THERAPEUTICS, INC. | Chief Financial Officer | Stock Option (right to buy) | 24.5K | Jan 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SEEL | SEELOS THERAPEUTICS, INC. | Feb 29, 2024 | 1 | $457 | 4 | Mar 1, 2024 | Chief Financial Officer |
SEEL | SEELOS THERAPEUTICS, INC. | Jan 12, 2024 | 1 | $0 | 4 | Jan 17, 2024 | Chief Financial Officer |
SEEL | SEELOS THERAPEUTICS, INC. | Nov 30, 2023 | 1 | $100K | 4 | Dec 1, 2023 | Chief Financial Officer |
SEEL | SEELOS THERAPEUTICS, INC. | Aug 31, 2023 | 1 | $7.73K | 4 | Sep 1, 2023 | Chief Financial Officer |
SEEL | SEELOS THERAPEUTICS, INC. | Mar 30, 2023 | 2 | $0 | 4 | Mar 31, 2023 | Chief Financial Officer |
SEEL | SEELOS THERAPEUTICS, INC. | Feb 28, 2023 | 1 | $8.4K | 4 | Mar 2, 2023 | Chief Financial Officer |
SEEL | SEELOS THERAPEUTICS, INC. | Feb 28, 2022 | 1 | $11.3K | 4 | Mar 4, 2022 | Chief Financial Officer |
SEEL | SEELOS THERAPEUTICS, INC. | Jan 10, 2022 | 1 | $0 | 4 | Jan 11, 2022 | Chief Financial Officer |
SEEL | SEELOS THERAPEUTICS, INC. | Sep 1, 2021 | 0 | $0 | 3 | Sep 2, 2021 | Chief Financial Officer |